MindRank in Phase 3 trial with first AI-assisted new drug

--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-01-04 13:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Technology & AI, Economy & Finance, Financial Markets, Law & Courts, Drugs, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029
--------------------------------------------------------------------
>>> Read full article at South China Morning Post <<<
<-- Back to Home
< >
[Close]